M. Tashiro

G. Neumann, Y. Kawaoka, M. Tashiro, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

M. Tashiro, J. McKimm-Breschkin, P. Mohr, 2013, The Journal of antimicrobial chemotherapy.

Development of a reverse transcription loop-mediated isothermal amplification assay for the rapid diagnosis of avian influenza A (H7N9) virus infection.

M. Tashiro, I. Takayama, T. Kageyama, 2014, Journal of virological methods.

Development of a particle agglutination assay system for detecting Japanese encephalitis virus-specific human IgM, using hydroxyapatite-coated nylon beads.

I. Kurane, M. Tashiro, T. Takasaki, 2002, Journal of virological methods.

Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study

T. Nishino, M. Tashiro, Y. Obata, 2021, BMC Nephrology.

Isolation of influenza A H1N2 viruses from an outbreak in Yokohama City during the 2001-2002 influenza season in Japan.

M. Tashiro, T. Odagiri, S. Nakajima, 2003, Japanese journal of infectious diseases.

Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata

M. Tashiro, K. Yanagihara, H. Mukae, 2019, Front. Microbiol..

Title Autophagy-Inducing Factor Atg 1 Is Required for Virulence in thePathogenic Fungus Candida glabrata

M. Tashiro, K. Yanagihara, H. Mukae, 2019 .

Evaluation of reverse transcription loop‐mediated isothermal amplification assays for rapid diagnosis of pandemic influenza A/H1N1 2009 virus

T. Yoshikawa, M. Tashiro, T. Kageyama, 2011, Journal of medical virology.

Human H5N2 Avian Influenza Infection in Japan and the Factors Associated with High H5N2-Neutralizing Antibody Titer

M. Tashiro, S. Itamura, N. Okabe, 2008, Journal of epidemiology.

Detection of SARS-CoV-2 using qRT-PCR in saliva obtained from asymptomatic or mild COVID-19 patients, comparative analysis with matched nasopharyngeal samples

K. Morita, K. Ariyoshi, M. Tashiro, 2021, PloS one.

Timely production of A/Fujian-like influenza vaccine matching the 2003-2004 epidemic strain may have been possible using Madin-Darby canine kidney cells.

M. Tashiro, T. Odagiri, T. Nishimura, 2008, Vaccine.

Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.

M. Tashiro, Yoshimasa Takahashi, N. Kishida, 2011, Vaccine.

Characterization of neuraminidase inhibitor‐resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post‐pandemic periods in Japan

M. Imai, M. Tashiro, N. Kishida, 2013, Influenza and other respiratory viruses.

Epidemiology of SARS-CoV-2 infection in nursing facilities and the impact of their clusters in a Japanese core city

M. Tashiro, K. Izumikawa, Haruka Maeda, 2022, Journal of Infection and Chemotherapy.

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine

M. Tashiro, Y. Adachi, M. Ato, 2019, Heliyon.

Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis.

M. Tashiro, M. Ato, Yoshimasa Takahashi, 2013, Vaccine.

Selection of antigenically advanced variants of seasonal influenza viruses

D. Burke, Dayan Wang, N. Cox, 2016, Nature Microbiology.

Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes

M. Saijo, S. Morikawa, N. Nagata, 2007, International journal of experimental pathology.

Expansion of the global measles and rubella laboratory network 2005-09.

W. Bellini, P. Rota, P. Strebel, 2011, The Journal of infectious diseases.

Associations between Chest CT Abnormalities and Clinical Features in Patients with the Severe Fever with Thrombocytopenia Syndrome

S. Inoue, K. Morita, K. Ariyoshi, 2022, Viruses.

Development of a sensitive novel diagnostic kit for the highly pathogenic avian influenza A (H5N1) virus

M. Tashiro, S. Itamura, I. Takayama, 2014, BMC Infectious Diseases.

Recovery of Pathogenic Measles Virus from Cloned cDNA

Y. Nagai, N. Nagata, M. Takeda, 2000, Journal of Virology.

Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season.

Keiji Fukuda, Richard Webby, Takato Odagiri, 2010, Vaccine.

Comparative Nucleotide Sequence Analyses of the Entire Genomes of B95a Cell-Isolated and Vero Cell-Isolated Measles Viruses from the same Patient

M. Tashiro, K. Takeuchi, F. Kobune, 2004, Virus Genes.

Highly Attenuated Vaccinia Virus Dis as a Potential Sars Vaccine

T. Mizutani, S. Morikawa, K. Ishii, 2006, Advances in experimental medicine and biology.

Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs

T. Mizutani, S. Morikawa, K. Ishii, 2006, Virology.

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness

R. Webster, R. Webby, A. Kelso, 2014, mBio.

Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.

M. Tashiro, N. Yamamoto, Kazuya Nakamura, 2019, Vaccine.

NS1-binding protein abrogates the elevation of cell viability by the influenza A virus NS1 protein in association with CRKL.

M. Tashiro, Shinya Tanaka, H. Hasegawa, 2013, Biochemical and biophysical research communications.

Update: influenza activity--United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine.

M. Tashiro, A. Hay, I. Gust, 2000, MMWR. Morbidity and mortality weekly report.

Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.

T. Ichinohe, M. Imai, M. Tashiro, 2007, Microbes and infection.

The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.

M. Tashiro, K. Yanagihara, K. Kosai, 2016, Medical mycology.

A mortality prediction rule for non-elderly patients with community-acquired pneumonia

K. Fushimi, M. Tashiro, K. Yanagihara, 2016, BMC Pulmonary Medicine.

Pulmonary Nocardiosis Caused by Nocardia concava with a Literature Review.

M. Tashiro, K. Yanagihara, K. Kosai, 2016, Internal medicine.

Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: Divergence of clade 2·2 viruses

Gavin J. D. Smith, Y. Guan, R. Webster, 2009 .

An Autopsy Case of Disseminated Varicella Zoster Virus Infection during the Treatment of Nephrotic Syndrome

T. Nishino, H. Hayashi, M. Tashiro, 2021, Internal medicine.

Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies.

I. Kurane, S. Morikawa, K. Ishii, 2005, Japanese journal of infectious diseases.

Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan

Makoto Ujike, M. Tashiro, H. Hasegawa, 2015, PloS one.

Molecular analysis of genome of the pandemic influenza A(H1N1) 2009 virus associated with fatal infections in Gunma, Tochigi, Yamagata, and Yamaguchi prefectures in Japan during the first pandemic wave.

M. Tashiro, K. Shirabe, H. Kimura, 2012, Japanese journal of infectious diseases.

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007

C. Macken, F. Hayden, M. Zambon, 2009, Antiviral therapy.

Influenza viruses, cell enzymes, and pathogenicity.

H. Klenk, Y. Nagai, M. Tashiro, 1995, American journal of respiratory and critical care medicine.

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

Y. Guan, M. Peiris, K. Fujii, 2006, Vaccine.

Genetics and infectivity of H5N1 highly pathogenic avian influenza viruses isolated from chickens and wild birds in Japan during 2010-11.

M. Tashiro, E. Nobusawa, A. Kawaguchi, 2012, Virus research.

The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination.

T. Odai, N. Nagata, M. Tashiro, 2010, Japanese journal of infectious diseases.

Nationwide surveillance of AIDS-defining illnesses among HIV patients in Japan from 1995 to 2017

M. Tashiro, K. Izumikawa, K. Teruya, 2021, PloS one.

Immunological and PCR Analyses for Borna Disease Virus in Psychiatric Patients and Blood Donors in Japan

K. Yamaguchi, N. Mori, M. Tashiro, 2001, Journal of Clinical Microbiology.

Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season.

Makoto Ujike, M. Tashiro, T. Odagiri, 2009, Japanese journal of infectious diseases.

Enhancement of SARS-CoV Infection by Proteases

S. Fukushi, S. Morikawa, K. Ishii, 2006, Advances in Experimental Medicine and Biology.

Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.

M. Imai, M. Tashiro, T. Odagiri, 2007, Vaccine.

Rapid Detection of the Severe Acute Respiratory Syn- drome (SARS) Coronavirus by a Loop-Mediated Iso-

Y. Guan, L. Poon, Kwok-Hung Chan, 2004 .

Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus

Yukiko Shimizu, T. Okamura, S. Fukushi, 2019, Journal of Virology.

Non Susceptibility of Neonatal and Adult Rats against the Middle East Respiratory Syndrome Coronavirus.

S. Fukushi, N. Nagata, M. Takeda, 2016, Japanese journal of infectious diseases.

Interactions between bacteria and influenza A virus in the development of influenza pneumonia.

H. Scheiblauer, M. Tashiro, R. Rott, 1992, The Journal of infectious diseases.

Role of Staphylococcus protease in the development of influenza pneumonia

H. Klenk, P. Ciborowski, M. Tashiro, 1987, Nature.

Effects of Toll-like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c 1

S. Morikawa, A. Uda, N. Nagata, 2014 .

Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine

S. Morikawa, A. Uda, N. Nagata, 2014, Journal of Virology.

Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models

J. Peiris, J. Peiris, T. Nomura, 2007, Vaccine.

Development of Vaccines and Passive Immunotherapy Against Sars Coronavirus Using Mouse and Scid-PBL/hu Mouse Models

J. Peiris, T. Nomura, Pei-Jer Chen, 2006, Advances in Experimental Medicine and Biology.

Diagnosis of human respiratory syncytial virus infection using reverse transcription loop-mediated isothermal amplification

M. Saijo, F. Taguchi, K. Shirato, 2006, Journal of Virological Methods.

Determination of N-Linked Sialyl-Sugar Chains in the Lungs of Domestic Cats and Dogs in Thailand Susceptible to the Highly Pathogenic Avian Influenza Virus (H5N1)

H. Yagi, T. Songserm, M. Tashiro, 2009 .

Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection.

M. Tashiro, T. Iwasaki, T. Kurata, 2000, The Journal of general virology.

Avirulent Avian Influenza Virus as a Vaccine Strain against a Potential Human Pandemic

A. Takada, M. Tashiro, H. Kida, 1999, Journal of Virology.

Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus

T. Ichinohe, M. Imai, N. Nagata, 2007, Journal of medical virology.

Pathological and Virological Analyses of Severe Acute Respiratory Syndrome–Associated Coronavirus Infections in Experimantal Animals

M. Saijo, S. Morikawa, N. Nagata, 2006, Advances in experimental medicine and biology.

Transmission Studies Resume for Avian Flu

Y. Guan, R. Webster, R. Webby, 2013, Science.

Pause on avian flu transmission research.

Y. Guan, R. Webster, R. Webby, 2012, Science.

Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses

C. Macken, R. Webster, A. Monto, 2005, Antiviral therapy.

Molecular evolution of the VP1, VP2, and VP3 genes in human rhinovirus species C

A. Ryo, T. Kusaka, M. Tashiro, 2015, Scientific Reports.

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir

Makoto Ujike, M. Tashiro, T. Odagiri, 2010, Virology Journal.

Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection

N. Nagata, M. Tashiro, Tadaki Suzuki, 2017, PloS one.

MutantsMonoclonal Antibody Escape Molecule of A/(H1N1)pdm09 Influenza Virus Epitope Mapping of the Hemagglutinin

M. Tashiro, T. Onodera, Kazuo Kobayashi, 2014 .

Epitope Mapping of the Hemagglutinin Molecule of A/(H1N1)pdm09 Influenza Virus by Using Monoclonal Antibody Escape Mutants

M. Tashiro, T. Onodera, Kazuo Kobayashi, 2014, Journal of Virology.

Rapid discrimination of oseltamivir‐resistant 275Y and ‐susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one‐step RT‐PCR assay†

Makoto Ujike, M. Tashiro, M. Ejima, 2011, Journal of medical virology.

A prime-boost vaccination of mice with heterologous H5N1 strains.

M. Tashiro, T. Odagiri, S. Itamura, 2009, Vaccine.

Evaluation of a novel vesicular stomatitis virus pseudotype‐based assay for detection of neutralizing antibody responses to SARS‐CoV

T. Mizutani, S. Fukushi, M. Saijo, 2006, Journal of medical virology.

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

Y. Guan, M. Peiris, Y. Kawaoka, 2004, The Journal of veterinary medical science.

Possible involvement of microtubule disruption in bipolar budding of a Sendai virus mutant, F1-R, in epithelial MDCK cells

H. Klenk, M. Tashiro, R. Rott, 1993, Journal of virology.

Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.

M. Tashiro, M. Kidokoro, H. Shida, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan.

T. Umeyama, M. Tashiro, K. Yanagihara, 2013, Medical mycology.

Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus

H. Klenk, M. Tashiro, N. McQueen, 1996, Journal of virology.

Differences in the priming effect of various clades/subclades of inactivated H5N1 vaccine for booster injection with heterologous clades of vaccine strains.

M. Tashiro, T. Odagiri, S. Itamura, 2011, Vaccine.

Lung fibrosis 10 years after cessation of bleomycin therapy.

M. Tashiro, H. Mukae, S. Kohno, 2008, The Tohoku journal of experimental medicine.

Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses.

H. Ariga, H. Kido, T. Towatari, 1997, Journal of biochemistry.

PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.

T. Ichinohe, M. Tashiro, T. Sata, 2009, Vaccine.

Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward.

M. Tashiro, K. Yanagihara, Y. Morinaga, 2011, Medical mycology.

Title Adjunctive corticosteroid therapy for inpatients with Mycoplasmapneumoniae pneumonia

K. Fushimi, M. Tashiro, K. Yanagihara, 2019 .

Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period: A Single-Center Retrospective Study

T. Nabeshima, K. Morita, K. Ariyoshi, 2022, Journal of clinical medicine.

Effects of surgical masks on droplet and aerosol dispersion under various oxygen delivery modalities

M. Tashiro, K. Yanagihara, H. Mukae, 2021, medRxiv.

Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step

M. Tashiro, T. Odagiri, 1997, Journal of virology.

Significance of basolateral domain of polarized MDCK cells for Sendai virus-induced cell fusion

H. Klenk, M. Tashiro, R. Rott, 2005, Archives of Virology.

Determinants of organ tropism of sendai virus.

M. Tashiro, N. McQueen, J. Seto, 1997, Frontiers in bioscience : a journal and virtual library.

Pneumotropism of Sendai Virus in Relation to Protease-Mediated Activation in Mouse Lungs

M. Tashiro, M. Homma, 1983, Infection and immunity.

Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis.

M. Tashiro, K. Yanagihara, H. Mukae, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Seroprevalence of a novel influenza A (H3N2) variant virus in the Japanese population.

M. Imai, M. Tashiro, N. Kishida, 2013, Japanese journal of infectious diseases.

A Global Lab Against Influenza

N. Cox, J. Taubenberger, D. Lavanchy, 2001, Science.

Induction of cross‐protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia

T. Ichinohe, M. Tashiro, Hidehiro Takahashi, 2010, Journal of medical virology.

Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.

M. Tashiro, T. Sata, H. Hasegawa, 2009, The Journal of infectious diseases.

A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.

M. Kiso, M. Tashiro, H. Hiramatsu, 2016, Journal of medicinal chemistry.

Advance Publication by J-STAGE jea JE2007446

Izumi, M. Tashiro, S. Itamura, 2008 .

[Dual use research of concern issue on publications of H5N1 highly pathogenic avian influenza virus mutants with pandemic potential in humans].

M. Tashiro, 2012, Uirusu.

IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration

M. Tashiro, Tadaki Suzuki, H. Hasegawa, 2018, Human Vaccines & Immunotherapeutics.

Immunogenicity of an inactivated adjuvanted whole‐virion influenza A (H5N1, NIBRG‐14) vaccine administered by intramuscular or subcutaneous injection

M. Tashiro, T. Odagiri, S. Itamura, 2010, Microbiology and immunology.

Detection of invasive pulmonary aspergillosis in mice using lung perfusion single-photon emission computed tomography with [99mTc]MAA.

T. Kudo, M. Tashiro, K. Yanagihara, 2020, Medical mycology.

[Survival Strategies of Aspergillus in the Human Body].

M. Tashiro, K. Izumikawa, 2017, Medical mycology journal.

Successful Treatment of Aspergillus Empyema Using Open Window Thoracostomy Salvage Treatment and the Local Administration of an Antifungal Agent.

M. Tashiro, K. Yanagihara, S. Kohno, 2016, Internal medicine.

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine

M. Tashiro, Tadaki Suzuki, H. Hasegawa, 2020, Microbiology and immunology.

Detection sensitivity of influenza rapid diagnostic tests

Y. Kawaoka, M. Tashiro, Kazuo Takahashi, 2014, Microbiology and immunology.

Intranasal administration of adjuvant‐combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus

T. Ichinohe, N. Nagata, M. Tashiro, 2010, Journal of medical virology.

Attenuation of a human H9N2 influenza virus in mammalian host by reassortment with an avian influenza virus

M. Tashiro, W. Lim, T. Saito, 2004, Archives of Virology.

Molecular Epidemiology and Antigenic Characterization of Seasonal Influenza Viruses Circulating in Nepal.

M. Banjara, B. Upadhyay, M. Tashiro, 2017, Journal of Nepal Health Research Council.

Differences in clinical manifestations of influenza‐associated encephalopathy by age

M. Hosoya, M. Tashiro, Y. Okuno, 2009, Microbiology and immunology.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Ron A M Fouchier, Colin A Russell, Takato Odagiri, 2008, Vaccine.

Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014

N. Hieu, M. Tashiro, T. Odagiri, 2016, Emerging infectious diseases.

Intermolecular association of HANA glycoprotein of Sendai virus in relation to the expression of biological activities.

M. Tashiro, M. Homma, K. Sugawara, 1982, Virology.

Influenza virus‐induced encephalopathy: Clinicopathologic study of an autopsied case

M. Tashiro, H. Kida, Tatsuo Yamada, 2000, Pediatrics international : official journal of the Japan Pediatric Society.

Influenza pandemic vaccines: the imminent challenges from a technical and regulatory perspective

R. Webster, R. Webby, N. Cox, 2004 .

Characteristics of azole-resistant Aspergillus fumigatus attached to agricultural products imported to Japan.

M. Tashiro, Yuichiro Nakano, T. Miyazaki, 2020, Journal of Infection and Chemotherapy.

Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.

M. Tashiro, K. Yanagihara, K. Ichihara, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Current Status of Drug-resistant Aspergillus.

M. Tashiro, K. Izumikawa, 2016, Medical mycology journal.

Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities

P. Wilairat, Yasuhiko Ito, M. Tashiro, 2009, Virology Journal.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen

M. Tashiro, K. Yanagihara, H. Mukae, 2017, The Journal of antimicrobial chemotherapy.

Executive Summary of JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Cryptococcosis 2019.

M. Tashiro, T. Sugita, F. Sakai, 2020, Medical mycology journal.

Inhibitory effect of a protease inhibitor, leupeptin, on the development of influenza pneumonia, mediated by concomitant bacteria.

H. Klenk, M. Tashiro, R. Rott, 1987, The Journal of general virology.

A reverse-type sandwich enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus

H. Kazamatsuri, M. Tashiro, T. Horimoto, 1997, Journal of clinical microbiology.

to Borna disease virus . immunosorbent assay for detecting antibodies A reverse-type sandwich enzyme-linked

H. Kazamatsuri, M. Tashiro, T. Horimoto, 1997 .

Mumefural and related HMF derivatives from Japanese apricot fruit juice concentrate show multiple inhibitory effects on pandemic influenza A (H1N1) virus

Makoto Ujike, M. Tashiro, N. Sriwilaijaroen, 2011 .

Evolution of H5N1 Avian Influenza Viruses in Asia

Keiji Fukuda, David E. Swayne, Nguyen Tien Dung, 2005, Emerging infectious diseases.

Suitability of NIID‐MDCK cells as a substrate for cell‐based influenza vaccine development from the perspective of adventitious virus susceptibility

M. Tashiro, N. Yamamoto, Kazuya Nakamura, 2022, Microbiology and immunology.

Mutations at the monomer–monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs

M. Imai, M. Tashiro, N. Kishida, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses

C. Macken, R. Webster, A. Monto, 2005, Antiviral Therapy.

Clinical and microbiological characteristics and challenges in diagnosing infected aneurysm: a retrospective observational study from a single center in Japan

K. Ariyoshi, M. Tashiro, K. Izumikawa, 2022, BMC Infectious Diseases.

Characterization of Seasonal Influenza Virus Type and Subtypes Isolated from Influenza Like Illness Cases of 2012.

M. Banjara, B. Upadhyay, M. Tashiro, 2017, Kathmandu University medical journal.

Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.

H. Klenk, M. Tashiro, R. Rott, 1991, Virology.

Influenza C Virus Infection in Rats

M. Tashiro, K. Nakamura, Kiyoto Nakamura, 1990, Microbiology and immunology.

Genetic variation among human strains of influenza C virus isolated in Japan.

M. Tashiro, F. Kitame, M. Homma, 1986, Virus research.

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses†

Thomas S. Peat, Janet Newman, Takehiko Saito, 2010, Journal of medicinal chemistry.

Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests

M. Tashiro, K. Yanagihara, H. Mukae, 2021, Journal of Infection and Chemotherapy.

Rapid development of a mycotic aneurysm of the intracranial artery secondary to Scedosporium apiospermum sinusitis

M. Tashiro, K. Izumikawa, Y. Ogawa, 2016, Medical mycology case reports.

Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan

T. Nishino, M. Tashiro, K. Yanagihara, 2011, Antimicrobial Agents and Chemotherapy.

A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels.

M. Tashiro, K. Yanagihara, K. Kamei, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study

T. Nishino, M. Tashiro, Y. Obata, 2022, Renal failure.

Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan

T. Nishino, M. Tashiro, Y. Obata, 2020, Scientific Reports.

Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice

M. Tashiro, R. Rott, K. Tobita, 2005, Archives of Virology.

Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.

K. Tateda, A. Ohno, Y. Ishii, 2012, Medical mycology.

Aggravation of pathogenicity of an avian influenza virus by adaptation to quails

M. Tashiro, R. Rott, M. Reinacher, 2005, Archives of Virology.

Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis

M. Tashiro, K. Yanagihara, H. Mukae, 2019, Journal of Clinical Microbiology.

Management of chronic pulmonary aspergillosis

M. Tashiro, S. Kohno, K. Izumikawa, 2012, Annals of the New York Academy of Sciences.

Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus

T. Nishino, M. Tashiro, K. Yanagihara, 2012, Antimicrobial Agents and Chemotherapy.

Serum Cytokines Usefulness for Understanding the Pathology in Allergic Bronchopulmonary Aspergillosis and Chronic Pulmonary Aspergillosis

Y. Obase, M. Tashiro, K. Yanagihara, 2022, Journal of fungi.

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia

K. Fushimi, M. Tashiro, K. Yanagihara, 2017, BMC Pulmonary Medicine.

Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study

K. Fushimi, M. Tashiro, K. Yanagihara, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

THE IMPACT OF FURTHER KNOWLEDGE OF THE AVIAN INFLUENZA VIRUSES

M. Tashiro, R. Rott, 2015 .

Current status of drug-resistant Aspergillus : evolution of resistance and future

M. Tashiro, S. Kohno, K. Izumikawa, 2013 .

Recombinant Wild-Type and Edmonston Strain Measles Viruses Bearing Heterologous H Proteins: Role of H Protein in Cell Fusion and Host Cell Specificity

M. Takeda, M. Tashiro, K. Takeuchi, 2002, Journal of Virology.

Evaluation of Influenza Virus A/H3N2 and B Vaccines on the Basis of Cross-Reactivity of Postvaccination Human Serum Antibodies against Influenza Viruses A/H3N2 and B Isolated in MDCK Cells and Embryonated Hen Eggs

H. Ikematsu, R. Saito, M. Tashiro, 2012, Clinical and Vaccine Immunology.

Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection.

Tsugunori Notomi, Takato Odagiri, Masato Tashiro, 2006, Vaccine.

Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin

M. Tashiro, M. Homma, Y. Mochizuki, 1988, Journal of virology.

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.

R. Webby, Dayan Wang, N. Cox, 2012, Vaccine.

Importance of the Anti-Interferon Capacity of Sendai Virus C Protein for Pathogenicity in Mice

Y. Nagai, A. Kato, M. Tashiro, 2007, Journal of Virology.

Characterization of the Amino Acid Residues of Sendai Virus C Protein That Are Critically Involved in Its Interferon Antagonism and RNA Synthesis Down-Regulation

Y. Nagai, A. Kato, M. Tashiro, 2004, Journal of Virology.

Absence of Carp's agent in sera of patients with multiple sclerosis in Japan.

M. Tashiro, M. Homma, Y. Ohara, 1982, Archives of neurology.

Mumps Virus V Protein Antagonizes Interferon without the Complete Degradation of STAT1

A. Kato, M. Tashiro, T. Kubota, 2005, Journal of Virology.

The Amino-Terminal Half of Sendai Virus C Protein Is Not Responsible for either Counteracting the Antiviral Action of Interferons or Down-Regulating Viral RNA Synthesis

Y. Nagai, A. Kato, M. Tashiro, 2002, Journal of Virology.

Y2, the Smallest of the Sendai Virus C Proteins, Is Fully Capable of both Counteracting the Antiviral Action of Interferons and Inhibiting Viral RNA Synthesis

Y. Nagai, A. Kato, M. Tashiro, 2001, Journal of Virology.

Versatility of the Accessory C Proteins of Sendai Virus: Contribution to Virus Assembly as an Additional Role

Y. Nagai, R. Yamaguchi, A. Kato, 2000, Journal of Virology.

Evidence of proteolytic activation of Sendai virus in mouse lung

M. Tashiro, M. Homma, 2005, Archives of Virology.

Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2

M. Tashiro, M. Homma, 1985, Journal of virology.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015

Ha T. Nguyen, Dayan Wang, S. Maurer-Stroh, 2014, Antiviral research.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

Dayan Wang, L. Gubareva, S. Leang, 2015, Antiviral research.

Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques

Ton de Jong, Kwok-Hung Chan, T. Kuiken, 2004, Nature Medicine.

Human immunodeficiency virus type 1 Nef protein on the cell surface is cytocidal for human CD4+ T cells

M. Tashiro, A. Adachi, K. Otake, 1996, FEBS letters.

Clinical Differentiation of Severe Fever with Thrombocytopenia Syndrome from Japanese Spotted Fever

K. Morita, K. Ariyoshi, M. Tashiro, 2022, Viruses.

Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation

T. Hashikawa, M. Tashiro, Yuko Sato, 2004, Acta Neuropathologica.

Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata

Hironobu Nakayama, M. Tashiro, K. Yanagihara, 2020, Scientific Reports.

Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir

F. Hayden, M. Zambon, M. Tashiro, 2003, Antimicrobial Agents and Chemotherapy.

Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells.

H. Kido, M. Tashiro, K. Sakai, 1994, The European respiratory journal.

Nucleoprotein gene analysis of fixed and street rabies virus variants using RT-PCR

Y. Kameoka, M. Tashiro, T. Horimoto, 1997, Archives of Virology.

Encephalitis and encephalopathy associated with an influenza epidemic in Japan.

M. Tashiro, Y. Okuno, N. Okabe, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The world first two cases of severe fever with thrombocytopenia syndrome: An epidemiological study in Nagasaki, Japan.

Fuxun Yu, K. Morita, M. Shimojima, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Detection of viral RNA in diverse body fluids in an SFTS patient with encephalopathy, gastrointestinal bleeding and pneumonia: a case report and literature review

K. Morita, M. Shimojima, M. Saijo, 2020, BMC Infectious Diseases.

One-step real-time reverse transcription-PCR assays for detecting and subtyping pandemic influenza A/H1N1 2009, seasonal influenza A/H1N1, and seasonal influenza A/H3N2 viruses

Tomoyuki N. Tanaka, M. Tashiro, T. Kageyama, 2010, Journal of Virological Methods.

Rapid Detection of the Severe Acute Respiratory Syndrome (SARS) Coronavirus by a Loop-Mediated Isothermal Amplification Assay

Y. Guan, J. Peiris, L. Poon, 2004, Clinical chemistry.

Epitope mapping of murine monoclonal antibodies against human immunodeficiency virus type 1 Nef.

M. Tashiro, A. Adachi, J. Kitoh, 1997, Experimental animals.

Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan

K. Morita, M. Tashiro, K. Yanagihara, 2019, Emerging infectious diseases.

Neritic squid resources and cuttlefish resources in Japan

M. Tashiro, Y. Natsukari, 1991 .

The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses

Y. Kawaoka, K. Shirato, M. Takeda, 2014, Journal of Virology.

Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment

M. Tashiro, K. Yanagihara, H. Mukae, 2016, Internal medicine.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010

Sarah Cobey, Neil Ferguson, Maria Zambon, 2013, Influenza and other respiratory viruses.

Hydroxyapatite-coated nylon beads as a new reagent to develop a particle agglutination assay system for detecting Japanese encephalitis virus-specific human antibodies.

I. Kurane, M. Tashiro, A. Yamamoto, 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Clinical significance of methicillin-resistant coagulase-negative staphylococci obtained from sterile specimens.

M. Tashiro, K. Izumikawa, Yoshihiro Yamamoto, 2015, Diagnostic microbiology and infectious disease.

Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.

M. Tashiro, R. Gejo, Tomoatsu Kimura, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus in a renal dysfunction patient undergoing adjustments to the linezolid dose.

H. To, M. Tashiro, K. Fukahara, 2015, Internal medicine.

Cyclosporin A inhibits the propagation of influenza virus by interfering with a late event in the virus life cycle.

M. Tashiro, N. Yamamoto, H. Takaku, 2013, Japanese journal of infectious diseases.

HIV‐1 Nef protein‐induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95(Fas)

M. Tashiro, H. Okada, Ryoichi Takei, 1997, FEBS letters.

Detection of Borna disease virus genome in normal human brain tissue

K. Arima, K. Ikuta, M. Tashiro, 1997, Brain Research.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013

Dayan Wang, L. Gubareva, A. Hurt, 2014, Antiviral research.

Molecular evolution of attachment glycoprotein (G) gene in human respiratory syncytial virus detected in Japan 2008-2011.

A. Ryo, T. Kusaka, M. Tashiro, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Global circulation patterns of seasonal influenza viruses vary with antigenic drift

Trevor Bedford, Colin A. Russell, Derek J. Smith, 2015, Nature.

Characterization of H7N9 influenza A viruses isolated from humans

Noriko Kishida, Ryan McBride, Amie J. Eisfeld, 2013, Nature.

Development of an assay for the detection and quantification of the measles virus nucleoprotein (N) gene using real-time reverse transcriptase PCR.

M. Tashiro, N. Okabe, H. Kimura, 2009, Journal of medical microbiology.

Molecular Evolutionary Analysis of the Influenza A(H1N1)pdm, May–September, 2009: Temporal and Spatial Spreading Profile of the Viruses in Japan

Noriko Kishida, Hiroshi Horikawa, Teruko Doi, 2010, PloS one.

Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.

Park Young-Joon, Philippe Buchy, Amanda Balish, 2013, Western Pacific surveillance and response journal : WPSAR.

High Yield Production of Influenza Virus in Madin Darby Canine Kidney (MDCK) Cells with Stable Knockdown of IRF7

M. Tashiro, N. Yamamoto, H. Takaku, 2013, PloS one.

Blood Donors in Japan Disease Virus in Psychiatric Patients and Immunological and PCR Analyses for Borna

K. Yamaguchi, M. Tashiro, T. Horimoto, 2001 .

[Borna disease virus infection].

M. Tashiro, T. Saito, 1999, Ryoikibetsu shokogun shirizu.

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice

S. Morikawa, K. Ishii, M. Tashiro, 2004, International immunology.

Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus

M. Tashiro, Tadaki Suzuki, H. Hasegawa, 2015, Proceedings of the National Academy of Sciences.

Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvant

M. Tashiro, H. Hasegawa, A. Ainai, 2011, Human vaccines.

Whole-Virion Influenza Vaccine Recalls an Early Burst of High-Affinity Memory B Cell Response through TLR Signaling

T. Kurosaki, M. Tashiro, T. Onodera, 2016, The Journal of Immunology.

This information is current as Response through TLR Signaling Early Burst of High-Affinity Memory B Cell Whole-Virion Influenza Vaccine

T. Kurosaki, M. Tashiro, T. Onodera, 2016 .

In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4+ T cells without MHC restriction.

M. Tashiro, A. Adachi, K. Otake, 1996, The Journal of general virology.

Virus Infection Triggers SUMOylation of IRF3 and IRF7, Leading to the Negative Regulation of Type I Interferon Gene Expression*

Masato Tashiro, Keiko Ozato, Toru Kubota, 2008, Journal of Biological Chemistry.

Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus.

M. Tashiro, N. Nakajima, Kazuo Kobayashi, 2012, Japanese journal of infectious diseases.

Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine

T. Ichinohe, M. Tashiro, T. Sata, 2010, Journal of medical virology.

Cell tropism of wild-type measles virus is affected by amino acid substitutions in the P, V and M proteins, or by a truncation in the C protein.

K. Nagata, K. Hashimoto, M. Takeda, 2004, The Journal of general virology.

Hemorrhagic complications and thromboembolism during anticoagulant therapy in a coronavirus disease patient

K. Ariyoshi, M. Tashiro, K. Yanagihara, 2021 .

Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

Catherine Macken, Maria Zambon, Masato Tashiro, 2006, Antimicrobial Agents and Chemotherapy.

A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

M. Tashiro, T. Sata, H. Asanuma, 2012, Vaccine.

A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.

M. Imai, M. Tashiro, N. Kishida, 2012, Biochemical and biophysical research communications.

Two Distinctive Binding Modes of Endonuclease Inhibitors to the N-Terminal Region of Influenza Virus Polymerase Acidic Subunit.

M. Tashiro, N. Yamamoto, T. Odagiri, 2016, Biochemistry.

Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase.

S. Neya, M. Tashiro, N. Yamamoto, 2015, Bioorganic & medicinal chemistry.

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.

R. Webby, Dayan Wang, N. Cox, 2014, Vaccine.

Discrepancies in preferences regarding the care of terminal-phase pneumonia in elderly patients among patients, families, and doctors: A multicenter questionnaire survey in nagasaki, Japan.

N. Yamasaki, M. Tashiro, K. Yanagihara, 2020, Respiratory investigation.

Evaluation of endobronchial volatile sulfur compounds for rapid diagnosis of lung abscesses caused by obligate anaerobes using Oral Chroma™: A pilot study.

M. Tashiro, K. Yanagihara, H. Mukae, 2020, Respiratory investigation.

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice

J. Peiris, T. Nomura, S. Morikawa, 2005, Vaccine.

Long-term trend in serum (1,3)-β-D-glucan level in a man with chronic disseminated candidiasis treated with corticosteroids.

M. Tashiro, Y. Miyazaki, K. Izumikawa, 2021, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.

M. Uetani, M. Tashiro, K. Yanagihara, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay.

M. Tashiro, T. Odagiri, I. Takayama, 2013, Journal of Virological Methods.

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan

H. Horikawa, K. Shimabukuro, Makoto Ujike, 2010, Emerging infectious diseases.

Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.

G. Neumann, Y. Kawaoka, M. Tashiro, 2016, Antiviral research.

Impact of Plasma 5 Hydroxyindoleacetic Acid, a Serotonin Metabolite, on Clinical Severity in Acute Respiratory Distress Syndrome

M. Tashiro, M. Mori, K. Izumikawa, 2021, Frontiers in Medicine.

Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in Japan

M. Kiso, Y. Kawaoka, M. Tashiro, 2015, Antimicrobial Agents and Chemotherapy.

A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013.

M. Tashiro, M. Ejima, T. Odagiri, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Data report: calcareous nannofossil biostratigraphy of the lower Pleistocene in Holes C0002K and C0002L, IODP Expedition 338, Nankai Trough Seismogenic Zone Experiment

K. Kameo, M. Tashiro, D. Kuwano, 2021 .

Isolation and Characterization of Subacute Sclerosing Panencephalitis Virus (Yamagata‐1 Strain) from a Brain Autopsy

H. Konno, M. Tashiro, M. Homma, 1982, Microbiology and immunology.

Rapid diagnosis of H5N1 avian influenza virus infection by newly developed influenza H5 hemagglutinin gene-specific loop-mediated isothermal amplification method.

T. Notomi, N. Tien, M. Imai, 2007, Journal of virological methods.

, Catherine Their Use Surveillance during the First 3 Years of Neuraminidase Inhibitors in Global Detection of Influenza Viruses Resistant to

C. Macken, R. Webster, A. Monto, 2006 .

Vaccines and therapeutics against influenza virus infections

M. Tashiro, Takehiko Saito, 2000, Pediatrics international : official journal of the Japan Pediatric Society.

Impact of plasma 5-hydroxyindoleacetic acid, a serotonin metabolite, on clinical outcome in septic shock, and its effect on vascular permeability

O. Tasaki, M. Tashiro, M. Mori, 2021, Scientific Reports.

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines

Arnone Nithichanon, G. Lertmemongkolchai, M. Tashiro, 2017, Scientific Reports.

P1‐5: The cytokine balance of allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA)

Y. Obase, M. Tashiro, H. Mukae, 2021, Respirology.

Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen

T. Nabeshima, S. Inoue, Fuxun Yu, 2021, International journal of environmental research and public health.

Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host‐cell adaptation

M. Tashiro, Yasuo Suzuki, Takashi Suzuki, 2004, Journal of medical virology.

Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds

M. Tashiro, N. Yamamoto, T. Odagiri, 2019, Influenza and Other Respiratory Viruses.

Epidemiology of Coronavirus Disease Outbreak among Crewmembers on Cruise Ship, Nagasaki City, Japan, April 2020

M. Tashiro, K. Yanagihara, Y. Arima, 2021, Emerging infectious diseases.

Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus

M. Tashiro, M. Homma, K. Nakamura, 1988, Journal of virology.

Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity

H. Kido, M. Tashiro, R. Rott, 1992, Journal of virology.

Nucleotide sequence analyses of the genes encoding the HN, M, NP, P, and L proteins of two host range mutants of Sendai virus.

H. Klenk, M. Tashiro, R. Rott, 1990, Virology.

Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice.

H. Klenk, M. Tashiro, R. Rott, 1992, The Journal of general virology.

Pulmonary phaeohyphomycosis due to Exophiala dermatitidis in a patient with pulmonary non-tuberculous mycobacterial infection.

Y. Obase, M. Tashiro, K. Yanagihara, 2023, Journal of Infection and Chemotherapy.

Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages

M. Tashiro, H. Kubo, I. Takayama, 2014, Journal of Virological Methods.

Mechanism of drug resistance of hemagglutinin of influenza virus and potent scaffolds inhibiting its function.

M. Tashiro, N. Yamamoto, H. Takaku, 2012, ACS chemical biology.

Transmission Studies Resume for Avian Flu

Y. Guan, R. Webster, R. Webby, 2013, Science.

Pause on Avian Flu Transmission Research

John Steel, Paul G. Thomas, Yi Guan, 2012, Science.

Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010

N. Ferguson, A. Monto, N. Cox, 2011, Influenza and other respiratory viruses.

Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study.

T. Nishino, M. Tashiro, Y. Obata, 2021, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

E cacy of Early Administration of Liposomal Amphotericin B in Patients with Septic Shock: A Nationwide Observational Study

M. Tashiro, 2020 .

Phylogenetic and cluster analysis of human rhinovirus species A (HRV-A) isolated from children with acute respiratory infections in Yamagata, Japan.

M. Tashiro, N. Okabe, H. Kimura, 2010, Virus Research.

Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report

M. Tashiro, K. Yanagihara, H. Mukae, 2021, BMC Infectious Diseases.

Antibody against the carboxyl terminus of the F2 subunit of Sendai virus fusion glycoprotein inhibits proteolytic activation.

H. Kido, M. Tashiro, S. Tanaka, 1993, Virology.

Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs

H. Kido, M. Tashiro, K. Sakai, 2005, Archives of Virology.

Sendai vvirus iinfection cchanges tthe ssubcellular llocalization oof tryptase C Clara iin rrat bbronchiolar eepithelial ccells

H. Kido, M. Tashiro, K. Sakai, 1994 .

The role of proteolytic cleavage of viral glycoproteins in the pathogenesis of influenza virus infections

M. Tashiro, R. Rott, 1996 .

Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling

T. Nabeshima, K. Morita, M. Tashiro, 2021, Journal of Infection and Chemotherapy.

Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism.

N. Nagata, M. Takeda, M. Tashiro, 2003, Virus research.

A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness

A. Ryo, Y. Okayama, M. Tashiro, 2011, BMC infectious diseases.

Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non‐HIV Cryptococcal meningitis: A nationwide observational study

K. Fushimi, M. Tashiro, K. Yanagihara, 2022, Mycoses.

Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically?

T. Nagayasu, M. Tashiro, K. Yanagihara, 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Assessment of oral health in elderly patients with dementia by measuring volatile sulfur compounds and its relationship with pneumonia development: A pilot study.

Y. Obase, M. Tashiro, K. Yanagihara, 2021, Respiratory investigation.

TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus

Natthanan Sangsriratanakul, Katsuhiro Nakajima, Minori Kitazawa, 2016, Scientific Reports.

Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1N1 viruses: its role in viral hemagglutination and neuraminidase inhibition.

M. Tashiro, H. Hiramatsu, N. Sriwilaijaroen, 2012, Antiviral research.

Molecular epidemiology of the attachment glycoprotein (G) gene in respiratory syncytial virus in children with acute respiratory infection in Japan in 2009/2010.

A. Ryo, M. Tashiro, N. Yamamoto, 2012, Journal of medical microbiology.

Genotyping and phylogenetic analysis of the major genes in respiratory syncytial virus isolated from infants with bronchiolitis.

M. Tashiro, N. Okabe, H. Kimura, 2010, Japanese journal of infectious diseases.

Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells

M. Tashiro, T. Odagiri, E. Nobusawa, 2016, PloS one.

Attenuation of a human H 9 N 2 influenza virus in mammalian host by reassortment with an avian influenza virus

M. Tashiro, W. Lim, T. Saito, 2022 .

Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields

M. Tashiro, H. Hasegawa, T. Odagiri, 2023, PloS one.

A case series of chronic necrotizing pulmonary aspergillosis and a new proposal.

T. Nagayasu, M. Tashiro, K. Yanagihara, 2013, Japanese journal of infectious diseases.

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

Ton de Jong, Kwok-Hung Chan, T. Kuiken, 2004, Nature medicine.

Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain

K. Nagata, K. Mori, H. Ushirogawa, 2017, Journal of Virology.

Nef protein of HIV‐1 induces apoptotic cytolysis of murine lymphoid cells independently of CD95 (Fas) and its suppression by serine/threonine protein kinase inhibitors

M. Tashiro, H. Okada, Ryoichi Takei, 1997, FEBS letters.

OSELTAMIVIR-RESISTANT INFL UENZA VIRUSES A (H1N1) DURING 2007-2009 INFL UENZA SEASONS, JAPAN

H. Horikawa, K. Shimabukuro, M. Tashiro, 2010 .

, H 7 N 9 and Seasonal Influenza Viruses Replication of Emerging In Vivo Role in The Host Protease TMPRSS 2 Plays a Major

Y. Kawaoka, K. Shirato, M. Takeda, 2014 .

A Mutant H3N2 Influenza Virus Uses an Alternative Activation Mechanism in TMPRSS2 Knockout Mice by Loss of an Oligosaccharide in the Hemagglutinin Stalk Region

Katsuhiro Nakajima, Minori Kitazawa, K. Takehara, 2015, Journal of Virology.

Laboratory and Epidemiology Communications SARS Coronavirus-Infected Cells in Lung Detected by New In Situ Hybridization Technique

N. Nagata, M. Tashiro, T. Sata, 2003 .

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

Ton de Jong, Kwok-Hung Chan, T. Kuiken, 2004, Nature medicine.

Selection of antigenically advanced variants of seasonal influenza viruses

D. Burke, Dayan Wang, N. Cox, 2016, Nature Microbiology.

Inhibition of HIV‐1 Nef‐induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3

M. Tashiro, H. Okada, Ryouichi Takei, 1998, FEBS letters.

Persistence of viral genes in a variant of MDBK cell after productive replication of a mutant of influenza virus A/WSN

M. Urabe, M. Tashiro, T. Odagiri, 2005, Archives of Virology.

[Laboratory virological diagnosis of imported dengue cases].

M. Tashiro, T. Horimoto, G. Masuda, 1996, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells

H. Klenk, M. Tashiro, R. Rott, 1990, Journal of virology.

Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium

H. Klenk, M. Tashiro, R. Rott, 1990, Journal of virology.

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010

H. Horikawa, A. Oguchi, K. Shimabukuro, 2011, Emerging infectious diseases.

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

Ton de Jong, Kwok-Hung Chan, T. Kuiken, 2004, Nature medicine.

Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.

K. Tateda, A. Ohno, Y. Ishii, 2012, Medical mycology.

Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study.

T. Nishino, M. Tashiro, Y. Obata, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Detection of Antibody to M Protein of Measles Virus in Patients with Subacute Sclerosing Panencephalitis: A Comparative Study on Immunoprecipitation

M. Tashiro, M. Homma, Y. Ohara, 1985, Microbiology and immunology.

[Evaluation of the severity of community-acquired pneumonia based on the JRS and IDSA/ATS guidelines].

M. Tashiro, S. Kohno, H. Kakeya, 2008, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients

M. Tashiro, K. Yanagihara, H. Mukae, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients

M. Tashiro, K. Yanagihara, H. Mukae, 2018, Medical mycology.

Influenza activity--United States and worldwide, April-October 2000.

M. Tashiro, A. Hay, M. Gaglani, 2000, MMWR. Morbidity and mortality weekly report.

Intranasal administration of adjuvant‐combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus

T. Ichinohe, N. Nagata, M. Tashiro, 2010, Journal of medical virology.

Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.

M. Tashiro, E. Nobusawa, A. Kawaguchi, 2013, Japanese journal of infectious diseases.

Laboratory and Epidemiology Communications SARS Coronavirus-Infected Cells in Lung Detected by New In Situ Hybridization Technique

N. Nagata, M. Tashiro, T. Sata, 2003 .

Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial

K. Ariyoshi, N. Tachikawa, M. Tashiro, 2023, Medicine.

M. Tashiro, Yoshimasa Takahashi, N. Kishida, 2011, Vaccine.

Molecular epidemiology of the attachment glycoprotein (G) gene in respiratory syncytial virus in children with acute respiratory infection in Japan in 2009/2010.

A. Ryo, M. Tashiro, N. Yamamoto, 2012, Journal of medical microbiology.

Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis.

M. Tashiro, M. Ato, Yoshimasa Takahashi, 2013, Vaccine.

Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide.

Y. Hashimoto, M. Tashiro, T. Kuzuhara, 2010, Bioorganic & medicinal chemistry.